Evidence map›Paper›PMID 35767572›Full record

ArticlePLoS neglected tropical diseases2022

Scaling up of tsetse control to eliminate Gambian sleeping sickness in northern Uganda.

Andrew Hope, Albert Mugenyi, Johan Esterhuizen, Inaki Tirados, Lucas Cunningham, Gala Garrod, Mike J Lehane, Joshua Longbottom, Tn Clement Mangwiro, Mercy Opiyo and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 5 countries.

Andrew HopeLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Albert MugenyiCoordinating Office for Control of Trypanosomiasis in Uganda, Kampala, Uganda.
Johan EsterhuizenLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Inaki TiradosLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Lucas CunninghamLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Gala GarrodLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Mike J LehaneLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Joshua LongbottomLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Tn Clement MangwiroBindura University of Science Education, Bindura, Zimbabwe.
Mercy OpiyoLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Michelle StantonLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Steve J TorrLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.ORCID 0000-0001-9550-4030
Glyn A ValeSouthern African Centre for Epidemiological Modelling and Analysis, University of Stellenbosch, Stellenbosch, South Africa.
Charles WaiswaCoordinating Office for Control of Trypanosomiasis in Uganda, Kampala, Uganda.
Richard SelbyLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom.
Liverpool School of Tropical Medicine · GBCoordinating Office for Control of Trypanosomiasis in Uganda · UGBindura University of Science Education · ZWStellenbosch University · ZA

Funding

Biotechnology and Biological Sciences Research Council BB/L019035/1Biotechnology and Biological Sciences Research Council BB/P005888/1Biotechnology and Biological Sciences Research Council BB/S01375X/1
6 · The paper itself

Abstract

backgroundTsetse flies (Glossina) transmit Trypanosoma brucei gambiense which causes Gambian human African trypanosomiasis (gHAT) in Central and West Africa. Several countries use Tiny Targets, comprising insecticide-treated panels of material which attract and kill tsetse, as part of their national programmes to eliminate gHAT. We studied how the scale and arrangement of target deployment affected the efficacy of control. METHODOLOGY AND PRINCIPAL

findingsBetween 2012 and 2016, Tiny Targets were deployed biannually along the larger rivers of Arua, Maracha, Koboko and Yumbe districts in North West Uganda with the aim of reducing the abundance of tsetse to interrupt transmission. The extent of these deployments increased from ~250 km2 in 2012 to ~1600 km2 in 2015. The impact of Tiny Targets on tsetse populations was assessed by analysing catches of tsetse from a network of monitoring traps; sub-samples of captured tsetse were dissected to estimate their age and infection status. In addition, the condition of 780 targets (~195/district) was assessed for up to six months after deployment. In each district, mean daily catches of tsetse (G. fuscipes fuscipes) from monitoring traps declined significantly by >80% following the deployment of targets. The reduction was apparent for several kilometres on adjacent lengths of the same river but not in other rivers a kilometre or so away. Expansion of the operational area did not always produce higher levels of suppression or detectable change in the age structure or infection rates of the population, perhaps due to the failure to treat the smaller streams and/or invasion from adjacent untreated areas. The median effective life of a Tiny Target was 61 (41.8-80.2, 95% CI) days.

conclusionsScaling-up of tsetse control reduced the population of tsetse by >80% across the intervention area. Even better control might be achievable by tackling invasion of flies from infested areas within and outside the current intervention area. This might involve deploying more targets, especially along smaller rivers, and extending the effective life of Tiny Targets.

Indexed as

Trypanosomiasis, AfricanTsetse FliesAnimalsGambiaHumansInsect ControlUganda

Identifiers

PMID35767572
PMCPMC9275725
OpenAlexW4283724473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.